https://www.selleckchem.com/products/lxh254.html
To evaluate the preoperative diagnostic value of contrast-enhanced lymphatic ultrasound (CEUS) for the sentinel lymph node (SLN) status in early breast cancer. We prospectively recruited 102 consecutive patients with clinically node-negative early breast cancer from July 2021 to October 2021. All patients underwent conventional US and percutaneous CEUS examinations. The CEUS of SLNs were classified into four enhancement patterns homogeneous (I), featured inhomogeneous (II), focal defect (III), and no enhancement (IV). The diagnostic perf
Like
Comment
Share
